Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/89670
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTrahair, L.en
dc.contributor.authorHorowitz, M.en
dc.contributor.authorHausken, T.en
dc.contributor.authorFeinle-Bisset, C.en
dc.contributor.authorRayner, C.en
dc.contributor.authorJones, K.en
dc.date.issued2014en
dc.identifier.citationThe Journal of Clinical Endocrinology and Metabolism, 2014; 99(12):E2628-E2634en
dc.identifier.issn0021-972Xen
dc.identifier.issn1945-7197en
dc.identifier.urihttp://hdl.handle.net/2440/89670-
dc.description.abstractContext: Studies relating to the cardiovascular effects of glucagon-like peptide-1 (GLP-1) and its agonists, which slow gastric emptying, have not discriminated between fasting and postprandial, blood pressure (BP) and heart rate (HR). Objective: To determine whether exogenous GLP-1 modulates the effects of an intraduodenal (ID) glucose infusion on BP, HR and splanchnic blood flow in healthy older subjects. Design: Double-blind randomised trial. Setting: Community dwelling residents attending a clinical research laboratory. Patients: 10 healthy 'older' subjects (9M,1F; age 73.2 ± 1.5 yr). Interventions: Intravenous infusion of GLP-1 (0.9 pmol/kg/min), or saline (0.9%) for 90 min (t = -30 - 60 min). Between t = 0 - 60 min, ID glucose was infused at 3 kcal/min. Main Outcome Measures: BP and HR were assessed with an automated BP device, superior mesenteric artery (SMA) flow by Doppler ultrasonography and blood glucose and serum insulin were measured. Results: During the 'fasting' period (t = -30 - 0 min), GLP-1 had no effect on BP or HR. In response to ID glucose (t = 0 - 60 min), systolic BP decreased (P < 0.001), and both HR (P < 0.001) and SMA flow (P < 0.05) increased, on both days. GLP-1 attenuated the maximum fall in systolic BP (P < 0.05), tended to increase HR (P = 0.09) and increased SMA flow (P < 0.01). GLP-1 diminished the glycemic response (P < 0.05). Conclusions: In healthy older subjects, acute administration of GLP-1 attenuates the hypotensive response to ID glucose, and potentiates the increase in SMA flow.en
dc.description.statementofresponsibilityLaurence G. Trahair, Michael Horowitz, Trygve Hausken, Christine Feinle-Bisset, Christopher K. Rayner, and Karen L. Jonesen
dc.language.isoenen
dc.publisherEndocrine Societyen
dc.rights© 2014 by the Endocrine Societyen
dc.subjectDuodenum; Mesenteric Arteries; Autonomic Nervous System; Humans; Insulin; Glucose; Blood Glucose; Double-Blind Method; Intubation, Gastrointestinal; Blood Pressure; Heart Rate; Splanchnic Circulation; Aged; Female; Male; Glucagon-Like Peptide 1en
dc.titleEffects of exogenous glucagon-like peptide-1 on the blood pressure, heart rate, mesenteric blood flow, and glycemic responses to intraduodenal glucose in healthy older subjectsen
dc.typeJournal articleen
dc.identifier.rmid0030014448en
dc.identifier.doi10.1210/jc.2014-2475en
dc.identifier.pubid107850-
pubs.library.collectionMedicine publicationsen
pubs.library.teamDS08en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]en
dc.identifier.orcidFeinle-Bisset, C. [0000-0001-6848-0125]en
dc.identifier.orcidRayner, C. [0000-0002-5527-256X]en
dc.identifier.orcidJones, K. [0000-0002-1155-5816]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.